CGS patients
incidence of CGS
costs of CGS
non-CGS
early ECMO
effective CGS intervention
high mortality
high risk of early death
high incidence of  chronic heart failure
novel strategy
Cardiogenic Shock Heart attacks
early use of ECMO
sick patients
EURO SHOCK
patients pa
early transfer
recurrent heart failure admissions
heart failure re-admissions
heart attack survivors
novel protocols
healthcare providers
novel cost effective framework
poor outcomes
healthcare costs
high risk sub-groups
technology providers
Europe
novel strategic approach
specialised ECMO SME
core
health-economic cost efficacy analysis
innovative healthcare technologies
month death rate
cardiac interventions
health economists
morbidity rate
ECG data
clear strategy
mechanistic data
true unmet clinical need
transfer networks
cardiac magnetic resonance imaging sub-study
s medical technology sector
associated socio-economic disease burden
ill-health
statisticians
Extracorporeal Membrane Oxygenation
expensive therapeutic devices
renowned physician-scientists
return
robust phase3 randomised trial
time activities
guidelines
life-long drugs
current standard of care
spiralling
multidisciplinary consortium
females
irrecoverable process
elderly
therapies
value
spiral of decline
Evidence